Events

CTSA Consortium Events: Events sponsored by the CTSA Consortium. Attendance is open to all members of the consortium.

CTSA Institutional Events: Events sponsored by CTSA Institutions. Attendance is open to all members of the consortium.

Other Events: Events sponsored by external partners of the CTSA Consortium that are related to clinical and translational research that might be of interest to CTSA members.

 

Interested in posting an event? Please submit your information here.

Microbiology for the CTSA 2017

Microbiology for the CTSA 2017

Location: Ann Arbor, MI

Date: 10-26-2017 8 a.m.

Event Sponsor By: Michigan Institute for Clinical & Health Research

Summary:

The NIH’s Clinical and Translational Science Award (CTSA) program has always emphasized the need for data standards to promote sharing and comparison of data across the CTSA Consortium and beyond. Yet creation and adoption of such standards is still painfully slow. Urgent action remains necessary. History shows the high value of standard terms, definitions, and symbols (i.e. ontology) to science.
Translational science requires a consistent set of standard ontologies spanning all scales, from molecule to organism to population.

In this year’s meeting we focus on ontology resources for describing data at the scale of micro-organisms.

Please click here to view more information.

INNOVATION LAB BUFFALO: Radical Solutions to the Opioid Misuse Epidemic

Innovation Lab Buffalo Call for Applications-2017-07-24

Please click here to view the application guidelines.

 

The Grand Challenge: 

Deaths from opioids have quadrupled in the past 15 years in the United States. Opioid mortality parallels increase in the quantity of legal prescription opioids dispensed. Abundance of prescription opioids paves the path to nonmedical use. Curbing opioid misuse is a major public health challenge, one that will require solutions involving diverse disciplines and perspectives. The NIH will be committing significant new funds to support grants to study the opioid epidemic in an effort to attract researchers new to this field to apply novel approaches from many disciplines to study this critical problem. The goal of this project is to facilitate the development of novel transdisciplinary collaborative grant proposals among early-career scholars. Enhancing collaboration is central to the CTSA program but faces many barriers. Early career investigators may face even greater challenges in pursuing and obtaining collaborative funding – without a substantive “nudge”. To provide that nudge, this project will implement Innovation Labs to Drive Early Career Grants designed to foster new transdisciplinary, multi-CTSA teams that will pursue radical science on opioid misuse.

www.buffalo.edu/innovationlabs

 

 

Mixed Methods Research Training Program for the Health Sciences

Mixed Methods Research Training Program for the Health Sciences

The program fulfills a national need for training in mixed methods and is a natural next step following the publication of the OBSSR “Best Practices for Mixed Methods Research in the Health Sciences.”  Selected scholars have access to webinars, resources, come to an in-person retreat to discuss their research project, and are matched with mixed methods expert consultants.  Our program has reported results in 3 peer-reviewed publications.

Mixed methods research is defined as the collection, analysis, and integration of both quantitative (e.g., RCT outcome) data and qualitative (e.g., observations, interviews) data to provide a more comprehensive understanding of a research problem than might be obtained through quantitative or qualitative research alone. Typical applications of mixed methods in the health sciences involve adding qualitative interviews to follow up on the outcomes of intervention trials, gathering both quantitative and qualitative data to assess patient reactions to a program implemented in a community health setting, or using qualitative data to explain the mechanism of a study correlating behavioral and social factors to specific health outcomes.

An increase in proposals submitted to NIH using mixed methods reflects the growing awareness of the importance of this approach in addressing population and behavioral health.

We are accepting applications for the 2018 scholar cohort.  We will accept applications through 5 pm on December 15, 2017.  Our mixed methods retreat is planned for June, 2018 in Baltimore, Maryland.

Please click here to view more information.

19th Annual HHS SBIR/STTR Conference In the Heartland of BioHealth Innovation

19th Annual HHS SBIR/STTR Conference In the Heartland of BioHealth Innovation

Location: Milwaukee, WI

Date: 11-07-2017 to  11-09-2017

Time: 7 am-7 pm, 7 am-8 pm, 7 am-5 pm

Summary:

This national, three-day event is designed to educate attendees about America’s Largest Seed Fund and how to access federal resources, develop competitive proposals, and secure awards. At over $920 million dollars of annual HHS funding, this is one of the largest sources of early-stage capital for technology commercialization in the United States.
Keynote Speaker: Dr. Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke (NINDS)
You will have the opportunity to:
Meet one-on-one with over 100 HHS representatives and discuss research opportunities
Understand HHS SBIR/STTR programs and funding opportunities
Learn about HHS assistance programs offered to awardees
Learn about the HHS SBIR/STTR application, review and award process
Discuss specific questions with HHS SBIR/STTR subject-matter experts
Build relationships with potential partners
Network with like-minded innovators
This conference is relevant to a diverse audience, including biomedical entrepreneurs; principal investigators; grants and contracts administrators; and industry partners.
Representatives from the National Institutes of Health (NIH), Small Business Administration (SBA), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will give presentations and answer questions during one-on-one meetings.

Please click here to view more information.

DIA Oligonucleotide-based Therapeutics Conference

DIA Oligonucleotide-based Therapeutics Conference

Location: North Bethesda, MD

Date: 10-27-2017 8:00 AM – 5:00 PM

Event Sponsor By: DIA

Summary:

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

This conference brings new thinking about the role and applications of oligonucleotide-based therapeutics in the medical product life cycle, with the intent of an exchange of ideas between FDA, industry, and academia. The conference places an emphasis on the alignment of CMC, Nonclinical, and Clinical knowledge with regulatory and translational science.

Please click here to view more information.